Citigroup Inc tiene un precio objetivo de consenso de $97.71 basado en las calificaciones de 19 analistas. El máximo es $134, emitido por Morgan Stanley el octubre 15, 2025. El mínimo es $65, emitido por Jefferies el abril 8, 2024. Las 3 calificaciones de analistas más recientes fueron publicadas por Keefe, Bruyette & Woods, B of A Securities y Barclays el octubre 17, 2025, octubre 15, 2025 y octubre 15, 2025, respectivamente. Con un precio objetivo promedio de $117.67 entre Keefe, Bruyette & Woods, B of A Securities y Barclays, hay una 15.96% upside implícita para Citigroup Inc según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/17/2025 | 16.29% | Keefe, Bruyette & Woods | $112 → $118 | Maintains | Outperform | |||
10/15/2025 | 18.26% | B of A Securities | $115 → $120 | Maintains | Buy | |||
10/15/2025 | 13.33% | Barclays | $100 → $115 | Maintains | Overweight | |||
10/15/2025 | 8.41% | TD Cowen | $105 → $110 | Maintains | Hold | |||
10/15/2025 | 8.41% | Piper Sandler | $107 → $110 | Maintains | Overweight | |||
10/15/2025 | 32.06% | Morgan Stanley | $129 → $134 | Maintains | Overweight | |||
09/29/2025 | 27.13% | Morgan Stanley | $107 → $129 | Maintains | Overweight | |||
09/24/2025 | 10.38% | Truist Securities | $105 → $112 | Maintains | Buy | |||
09/23/2025 | 21.22% | Oppenheimer | $124 → $123 | Maintains | Outperform | |||
09/16/2025 | 23.19% | Wells Fargo | $115 → $125 | Maintains | Overweight | |||
09/03/2025 | 3.48% | Truist Securities | $99 → $105 | Maintains | Buy | |||
07/30/2025 | 22.2% | Oppenheimer | $123 → $124 | Maintains | Outperform | |||
07/16/2025 | 13.33% | Wells Fargo | $110 → $115 | Maintains | Overweight | |||
07/16/2025 | -2.43% | Truist Securities | $93 → $99 | Maintains | Buy | |||
07/16/2025 | 2.49% | Piper Sandler | $84 → $104 | Maintains | Overweight | |||
07/16/2025 | 21.22% | Oppenheimer | $107 → $123 | Maintains | Outperform | |||
07/16/2025 | -1.45% | Barclays | $95 → $100 | Maintains | Overweight | |||
07/16/2025 | -6.38% | TD Cowen | $85 → $95 | Maintains | Hold | |||
07/16/2025 | 5.45% | Morgan Stanley | $103 → $107 | Maintains | Overweight | |||
07/15/2025 | -12.29% | UBS | $89 → $89 | Maintains | Neutral | |||
07/09/2025 | -8.35% | Truist Securities | $84 → $93 | Maintains | Buy | |||
07/03/2025 | 1.51% | Morgan Stanley | $94 → $103 | Maintains | Overweight | |||
07/02/2025 | -5.39% | Goldman Sachs | $85 → $96 | Maintains | Buy | |||
07/02/2025 | -24.12% | Evercore ISI Group | $76 → $77 | Maintains | In-Line | |||
06/26/2025 | -1.45% | B of A Securities | $89 → $100 | Maintains | Buy | |||
06/23/2025 | -7.36% | Morgan Stanley | $90 → $94 | Maintains | Overweight | |||
06/10/2025 | -16.23% | Goldman Sachs | $75 → $85 | Maintains | Buy | |||
04/28/2025 | -7.36% | Oppenheimer | $91 → $94 | Maintains | Outperform | |||
04/16/2025 | -23.13% | RBC Capital | $85 → $78 | Maintains | Outperform | |||
04/16/2025 | -9.33% | Keefe, Bruyette & Woods | $96 → $92 | Reiterates | Outperform → Outperform | |||
04/16/2025 | -24.12% | Piper Sandler | $83 → $77 | Reiterates | Overweight → Overweight | |||
04/16/2025 | -22.14% | Truist Securities | $84 → $79 | Maintains | Buy | |||
04/04/2025 | -17.22% | Truist Securities | $85 → $84 | Maintains | Buy | |||
04/03/2025 | -25.59% | JP Morgan | $85.5 → $75.5 | Maintains | Neutral | |||
04/02/2025 | -12.29% | B of A Securities | $90 → $89 | Maintains | Buy | |||
04/01/2025 | -25.1% | Evercore ISI Group | $79 → $76 | Maintains | In-Line | |||
03/19/2025 | -21.16% | Goldman Sachs | $90 → $80 | Maintains | Buy | |||
03/13/2025 | 7.42% | Morgan Stanley | $110 → $109 | Maintains | Overweight | |||
03/10/2025 | -11.3% | B of A Securities | $100 → $90 | Maintains | Buy | |||
02/18/2025 | -1.45% | B of A Securities | $95 → $100 | Maintains | Buy | |||
01/29/2025 | -11.3% | Goldman Sachs | $86 → $90 | Maintains | Buy | |||
01/16/2025 | -16.23% | RBC Capital | $74 → $85 | Maintains | Outperform | |||
01/16/2025 | -14.26% | Argus Research | $72 → $87 | Maintains | Buy | |||
01/16/2025 | 7.42% | Morgan Stanley | $104 → $109 | Maintains | Overweight | |||
01/16/2025 | -22.14% | Evercore ISI Group | $69 → $79 | Maintains | In-Line | |||
01/16/2025 | -15.25% | Goldman Sachs | $77 → $86 | Maintains | Buy | |||
01/16/2025 | -9.33% | Keefe, Bruyette & Woods | $85 → $92 | Maintains | Outperform | |||
01/16/2025 | -18.2% | Piper Sandler | $80 → $83 | Reiterates | Overweight → Overweight | |||
01/07/2025 | -6.38% | B of A Securities | $90 → $95 | Maintains | Buy | |||
01/07/2025 | -16.23% | Truist Securities | — | → $85 | Initiates | → Buy | ||
01/06/2025 | -6.38% | Barclays | $70 → $95 | Upgrade | Equal-Weight → Overweight | |||
01/03/2025 | 8.41% | Wells Fargo | $95 → $110 | Maintains | Overweight | |||
01/03/2025 | -16.23% | Keefe, Bruyette & Woods | $82 → $85 | Maintains | Outperform | |||
01/03/2025 | 0.52% | Oppenheimer | $110 → $102 | Maintains | Outperform | |||
01/02/2025 | -32% | Evercore ISI Group | $66 → $69 | Maintains | In-Line | |||
12/06/2024 | -20.17% | Goldman Sachs | $72 → $81 | Maintains | Buy | |||
12/03/2024 | -19.19% | Keefe, Bruyette & Woods | $70 → $82 | Upgrade | Market Perform → Outperform | |||
12/03/2024 | -21.16% | Piper Sandler | $73 → $80 | Maintains | Overweight | |||
12/02/2024 | -11.3% | B of A Securities | $78 → $90 | Maintains | Buy | |||
11/15/2024 | -6.38% | Wells Fargo | $85 → $95 | Maintains | Overweight | |||
11/05/2024 | 5.45% | Oppenheimer | $91 → $107 | Maintains | Outperform | |||
10/16/2024 | -31.01% | Barclays | $63 → $70 | Maintains | Equal-Weight | |||
10/16/2024 | -36.93% | Evercore ISI Group | $63 → $64 | Maintains | In-Line | |||
10/16/2024 | -10.32% | Oppenheimer | $92 → $91 | Maintains | Outperform | |||
10/16/2024 | -19.19% | Morgan Stanley | $86 → $82 | Maintains | Overweight | |||
10/16/2024 | -23.13% | B of A Securities | $77 → $78 | Maintains | Buy | |||
10/02/2024 | -9.33% | Oppenheimer | $87 → $92 | Maintains | Outperform | |||
09/30/2024 | -15.25% | Morgan Stanley | $79 → $86 | Maintains | Overweight | |||
09/11/2024 | -30.03% | Goldman Sachs | $75 → $71 | Maintains | Buy | |||
07/30/2024 | -22.14% | Morgan Stanley | $66 → $79 | Maintains | Overweight | |||
07/15/2024 | -33.97% | BMO Capital | $65 → $67 | Maintains | Market Perform | |||
07/15/2024 | -29.04% | Argus Research | $70 → $72 | Maintains | Buy | |||
07/15/2024 | -28.06% | Piper Sandler | $70 → $73 | Reiterates | Overweight → Overweight | |||
07/15/2024 | -15.25% | Oppenheimer | $85 → $86 | Maintains | Outperform | |||
07/15/2024 | -34.96% | Morgan Stanley | $65 → $66 | Maintains | Overweight | |||
07/03/2024 | -38.9% | Evercore ISI Group | $60 → $62 | Maintains | In-Line | |||
06/20/2024 | -35.94% | Morgan Stanley | $65 → $65 | Maintains | Overweight | |||
06/20/2024 | -34.96% | RBC Capital | $66 → $66 | Reiterates | Outperform → Outperform | |||
06/20/2024 | -32% | Keefe, Bruyette & Woods | $66 → $69 | Maintains | Market Perform | |||
06/17/2024 | -34.96% | RBC Capital | $63 → $66 | Maintains | Outperform | |||
04/30/2024 | -15.25% | Oppenheimer | $87 → $86 | Maintains | Outperform | |||
04/15/2024 | -37.91% | BMO Capital | $61 → $63 | Maintains | Market Perform | |||
04/15/2024 | -31.01% | Argus Research | $60 → $70 | Maintains | Buy | |||
04/15/2024 | -31.01% | Piper Sandler | $67 → $70 | Maintains | Overweight | |||
04/15/2024 | -14.26% | Oppenheimer | $88 → $87 | Maintains | Outperform | |||
04/08/2024 | -35.94% | Jefferies | $56 → $65 | Maintains | Hold | |||
04/05/2024 | -34.96% | Keefe, Bruyette & Woods | $54 → $66 | Maintains | Market Perform | |||
04/01/2024 | — | Goldman Sachs | — | Maintains | Buy | |||
04/01/2024 | -21.16% | Wells Fargo | $80 → $80 | Maintains | Overweight | |||
03/28/2024 | -31.01% | HSBC | $61 → $70 | Maintains | Buy | |||
03/25/2024 | -21.16% | Wells Fargo | $70 → $80 | Maintains | Overweight | |||
03/19/2024 | -13.27% | Oppenheimer | $95 → $88 | Maintains | Outperform | |||
03/15/2024 | -32.99% | Goldman Sachs | $55 → $68 | Maintains | Buy | |||
03/14/2024 | -32.99% | Goldman Sachs | $55 → $68 | Upgrade | Neutral → Buy | |||
02/14/2024 | -37.91% | Piper Sandler | $56 → $63 | Upgrade | Neutral → Overweight | |||
01/30/2024 | -6.38% | Oppenheimer | $93 → $95 | Maintains | Outperform | |||
01/30/2024 | -35.94% | Morgan Stanley | $46 → $65 | Upgrade | Underweight → Overweight | |||
01/16/2024 | -8.35% | Oppenheimer | $85 → $93 | Maintains | Outperform | |||
01/16/2024 | -44.81% | Piper Sandler | $53 → $56 | Maintains | Neutral | |||
01/10/2024 | — | BMO Capital | — | Downgrade | Outperform → Market Perform |
El último precio objetivo de Citigroup (NYSE:C) fue comunicado por Keefe, Bruyette & Woods el octubre 17, 2025. La firma de analistas fijó un precio objetivo para $118.00 que espera C a rise dentro de 12 meses (un posible 16.29% upside). 60 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Citigroup (NYSE:C) fue proporcionada por Keefe, Bruyette & Woods, y Citigroup mantuvo su outperform calificación.
La última revisión al alza de Citigroup Inc se produjo en enero 6, 2025, cuando Barclays elevó su precio objetivo a $95. Barclays anteriormente tenía an equal-weight para Citigroup Inc.
La última revisión a la baja de Citigroup Inc se produjo en enero 10, 2024, cuando BMO Capital cambió su precio objetivo de N/A a N/A para Citigroup Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Citigroup, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Citigroup se registró el octubre 17, 2025, por lo que la próxima calificación estará disponible en torno al octubre 17, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Citigroup (C) fue un mantuvo con un precio objetivo de $112.00 a $118.00. El precio actual al que cotiza Citigroup (C) es de $101.47, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.